Gene · 442906
Papers1,644
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,644
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology. | Cancers (Basel) | 2023 | 37345019 | PubTator, text mining | PubMed |
| Remyelination in multiple sclerosis from the miRNA perspective. | Front Mol Neurosci | 2023 | 37333618 | PubTator, text mining | PubMed |
| LINC00943 regulates miR-1252-5p/YWHAH axis to promote tumor proliferation and metastasis in lung adenocarcinoma. | Heliyon | 2023 | 37332930 | PubTator, text mining | PubMed |
| LncRNA MALAT1 regulates growth of carcinoma of the lung through modulating miR-338-3p/PYCR2 axis. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37329534 | PubTator, text mining | PubMed |
| Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis. | Front Oncol | 2023 | 37324026 | PubTator, text mining | PubMed |
| Systems genetics identifies miRNA-mediated regulation of host response in COVID-19. | Hum Genomics | 2023 | 37303042 | PubTator, text mining | PubMed |
| Roles of Noncoding RNAs in Regulation of Mitochondrial Electron Transport Chain and Oxidative Phosphorylation. | Int J Mol Sci | 2023 | 37298366 | PubTator, text mining | PubMed |
| The Essential Role of microRNAs in Inflammatory and Autoimmune Skin Diseases-A Review. | Int J Mol Sci | 2023 | 37298095 | PubTator, text mining | PubMed |
| Endogenous and viral microRNAs in nasal secretions of water buffaloes (Bubalus bubalis) after Bubaline alphaherpesvirus 1 (BuHV-1) challenge infection. | Vet Res | 2023 | 37277883 | PubTator, text mining | PubMed |
| Circular RNA DHTKD1 targets miR‑338‑3p/ETS1 axis to regulate the inflammatory response in human bronchial epithelial cells. | Exp Ther Med | 2023 | 37273760 | PubTator, text mining | PubMed |
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view. | ESMO Open | 2023 | 37263082 | PubTator, text mining | PubMed |
| Adenovirus-associated anti-miRNA-214 regulates bone metabolism and prevents local osteoporosis in rats. | Front Bioeng Biotechnol | 2023 | 37251576 | PubTator, text mining | PubMed |
| Hypoxia-induced loss of SRSF2-dependent DNA methylation promotes CTCF-mediated alternative splicing of VEGFA in breast cancer. | iScience | 2023 | 37235058 | PubTator, text mining | PubMed |
| Plasma Extracellular Vesicle MicroRNA Analysis of Alzheimer's Disease Reveals Dysfunction of a Neural Correlation Network. | Research (Wash D C) | 2023 | 37223486 | PubTator, text mining | PubMed |
| Regulatory mechanisms and clinical applications of tumor-driven exosomal circRNAs in cancers. | Int J Med Sci | 2023 | 37213665 | PubTator, text mining | PubMed |
| Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment. | Front Pharmacol | 2023 | 37205904 | PubTator, text mining | PubMed |
| In Silico Analysis of MicroRNA Expression Data in Liver Cancer. | Cancer Inform | 2023 | 37200943 | PubTator, text mining | PubMed |
| MicroRNA, mRNA, and Proteomics Biomarkers and Therapeutic Targets for Improving Lung Cancer Treatment Outcomes. | Cancers (Basel) | 2023 | 37190222 | PubTator, text mining | PubMed |
| Role of Some microRNA/ADAM Proteins Axes in Gastrointestinal Cancers as a Novel Biomarkers and Potential Therapeutic Targets-A Review. | Curr Issues Mol Biol | 2023 | 37185715 | PubTator, text mining | PubMed |
| High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia. | Transl Cancer Res | 2023 | 37180663 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442906/papers?page=5